SINT
vs
S&P 500
SINT
S&P 500
Over the past 12 months, SINT has underperformed S&P 500, delivering a return of -4% compared to the S&P 500's +14% growth.
Stocks Performance
SINT vs S&P 500
Performance Gap
SINT vs S&P 500
Performance By Year
SINT vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SINTX Technologies Inc
Glance View
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 36 full-time employees. The company went IPO on 2014-02-11. The firm is focused on manufacturing, research and development of silicon nitride ceramics for external partners. The firm's medical-grade silicon nitride products includes FleX SN-MC2, FleX SN-CSC, FleX SN-PEEK and FleX SN-AP, which are biocompatible, bioactive, antipathogenic and has a bone affinity. The firm's antipathogenic product, FleX SN-AP, which is a silicon nitride antipathogenic powder used in manufacturing of products such as face masks and personal protective equipment. The firm's non-medical applications are used in manufacturing of ceramic armors for the aerospace and defense industries. Its industrial silicon nitride has a combination of mechanical, thermal and electrical properties of any technical ceramic material.